Here are five notes:
1. The LIBERATE Study is evaluating the long-term safety and effectiveness of the next generation of the Eclipse System, a vaginal bowel-control system, for the treatment of fecal incontinence.
2. An earlier study conducted at UAB, called the LIFE study, found that an earlier version of the Eclipse System could successfully control fecal incontinence.
3. The 12-month, national, multicenter LIBERATE Study will examine the next generation of the Eclipse system and further investigate its efficacy.
4. Holly Richter, PhD, MD, director of the division of urogynecology and pelvic reconstructive surgery at UAB, is the national principal investigator of the LIBERATE Study.
5. UAB Hospital is one of 15 centers in the United States that will participate in the trial and it is expected to enroll 150 patients.
More articles on GI/endoscopy:
CCFA names new president, CEO: 5 things to know
POEM endoscopic procedure effective in treating a number of esophageal motility disorders: 6 things to know
GI physician leader to know: Dr. Robert Sable of Riverdale Gastroenterology and Liver Diseases
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
